Inner Mongolia Furui Medical Science Co., Ltd. (SHE:300049)

Market Cap	14.76B +54.2%
Revenue (ttm)	1.47B +10.8%
Net Income	123.17M -5.5%
EPS	0.47 -4.4%
Shares Out	264.98M
PE Ratio	118.57
Forward PE	78.46
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,423,707
Average Volume	5,784,573
Open	55.65
Previous Close	56.99
Day's Range	54.81 - 56.66
52-Week Range	26.61 - 90.68
Beta	-0.40
RSI	27.29
Earnings Date	Mar 25, 2026

About SHE:300049

Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. The company operates in two segments: pharmaceutical production and sales; and diagnostic equipment R&D, production and sales. The pharmaceutical production and sales segment produces and sells products, such as Fufang Biejiaruangan tablets and shell fat capsules. The diagnostic equipment R&D, production and sales segment develops, produces, and sells the FibroScan series of liver fibrosis diagnostic instrument...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 867
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300049

Financial Performance

In 2024, SHE:300049's revenue was 1.35 billion, an increase of 16.93% compared to the previous year's 1.15 billion. Earnings were 113.29 million, an increase of 11.54%.